Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2019 · 10-Q
Revenue—
Net Income-$2.21M-$2.21Mno prior Q2 2018 on file EPS Diluted-$0.20-$0.20no prior Q2 2018 on file Operating Income-$1,521,100— Operating Cash Flowderived-$1,876,596—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 10, 2019 · 40 d after period end